Arkolith/Insider Trading/ITOS/Form 4

Detheux Michel

Chief Executive OfficeriTeos Therapeutics, Inc. (ITOS) · full profile →Form 4 · filed Jun 6, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.6M
Net Open-Market Flow
-$1.6M
Transactions
18
12 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 6, 2025Sell(S)44K$10.21$448K0
Jun 6, 2025Option exercise(M)44K$4.30$189K44K
Jun 6, 2025Sell(S)8K$10.21$86K136K
Jun 6, 2025Option exercise(M)8K$4.30$36K144K
Jun 5, 2025Option exercise(M)8K$4.30$36K144K
Jun 5, 2025Sell(S)8K$10.15$85K136K
Jun 5, 2025Option exercise(M)44K$4.30$189K44K
Jun 5, 2025Sell(S)44K$10.15$445K0
Jun 4, 2025Option exercise(M)8K$4.30$36K144K
Jun 4, 2025Sell(S)8K$10.10$85K136K
Jun 4, 2025Option exercise(M)44K$4.30$189K44K
Jun 4, 2025Sell(S)44K$10.10$443K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 6, 2025Option exercise(M)8K—$035K
Jun 6, 2025Option exercise(M)44K—$0182K
Jun 5, 2025Option exercise(M)8K—$043K
Jun 5, 2025Option exercise(M)44K—$0226K
Jun 4, 2025Option exercise(M)44K—$0270K
Jun 4, 2025Option exercise(M)8K—$052K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-083411) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML